Study findings showed that antibodies against the influenza surface protein neuraminidase are associated with a significantly shortened period of viral shedding in children and adults, and with shortened influenza symptom duration in adults, researchers reported in Clinical Infectious Diseases.

The researchers suggested that increasing anti-neuraminidase (anti-NA) immunity should be a priority for next-generation influenza vaccines.

Credit CDC

Read more at Healio…